Abstract:Functionalized dendrimer‐Cu(II) complexes are developed to deliver lactate oxidase for lactate depletion‐enhanced cancer therapy. The created complexes can promote the production of reactive oxygen species, interfere with the cell cycle, and accelerate lactate depletion, enabling alleviation of immunosuppresion to reprogram the local tumor microenvironment in combination with the immune agonist leukadherin‐1 to tackle both leukemia and glioma cancer models. Cancer cells engage in active aerobic glycolysis to meet their bioenergetic synthesis needs, which is known as the Warburg effect. Such a process leads to lactate accumulation in the tumor microenvironment (TME), further promoting cancer progression and inducing immunosuppression. Herein, functionalized dendrimer‐Cu(II) complexes (for short, D‐Cu(II)) as a nanocarrier, which enables a Fenton‐like reaction is developed to generate a large amount of hydroxyl radicals and shows a T1‐weighted magnetic resonance (MR) imaging performance. Importantly, the D‐Cu(II) allows efficient delivery of lactate oxidase (LOx) to cancer cells, directly downregulating the lactate levels. When combining with an immune activator of leukadherin‐1, the developed D‐Cu(II)/LOx complexes alleviate the symptoms of mouse leukemia. With a further coating of macrophage membranes, the generated D‐Cu(II)/LOx@M allows for effective blood‐brain barrier crossing to treat an orthotopic murine glioma model under the guidance of Cu(II)‐facilitated MR imaging. By integrating the LOx‐mediated lactate depletion with Cu(II)‐mediated chemodynamic therapy, the developed dendrimer nanomedicines improve the overall survival and antitumor immune responses of mice, and help to remodel the immunosuppressive TME in both cancer models, greatly sensitizing the treatment efficacy of immune activator. Such dendrimer technology may further be used for theranostics of other cancer types through lactate depletion‐enhanced combinational therapy.

Development of functional dendrisomes based on a single molecule of polyesterbenzylether dendrimer and their application in cancer stem cell therapy

The architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention.

Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor

In Vitro Validation of the Therapeutic Potential of Dendrimer-Based Nanoformulations against Tumor Stem Cells

Research Status of Dendrimer Micelles in Tumor Therapy for Drug Delivery

Manipulating Redox Homeostasis of Cancer Stem Cells Overcome Chemotherapeutic Resistance Through Photoactivatable Biomimetic Nanodiscs.

A Small-Molecule Self-Assembled Nanodrug for Combination Therapy of Photothermal-Differentiation-chemotherapy of Breast Cancer Stem Cells

Compound Nanoemulsion Combined with Differentiation/Cytotoxicity Drugs for Modulating Breast Cancer Stemness.

Core-shell Tecto Dendrimer-Mediated Cooperative Chemoimmunotherapy of Breast Cancer

Core-shell Tecto Dendrimers Co-Deliver Drug/gene for Immunomodulation of Macrophages and Dendritic Cells and Checkpoint Blockade-Promoted Breast Cancer Chemoimmunotherapy

Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations

Enhancing Therapeutic Effects of Docetaxel-Loaded Dendritic Copolymer Nanoparticles by Co-Treatment with Autophagy Inhibitor on Breast Cancer

Dendrimers for Cancer Immunotherapy: Avidity‐based Drug Delivery Vehicles for Effective Anti‐tumor Immune Response

A Dendritic Cell-Like Biomimetic Nanoparticle Enhances T Cell Activation for Breast Cancer Immunotherapy

Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy

A Non-Cytotoxic Dendrimer with Innate and Potent Anticancer and Anti-Metastatic Activities

AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data

Systemically targeting monocytic myeloid-derived suppressor cells using dendrimers and their cell-level biodistribution kinetics

Dendrimer‐Cu(II) Complexes Mediate Enzyme Delivery for Lactate Depletion‐Enhanced Combinational Treatment of Leukemia and Glioma

Sequential Responsive Multifunctional Nanomicelle Effectuates Collective Elimination of Breast Cancer and Cancer Stem Cells

Dual-Mode Imaging-Guided Synergistic Chemo- and Magnetohyperthermia Therapy in a Versatile Nanoplatform to Eliminate Cancer Stem Cells.